Man of Many on MSN
2026 Honda Civic Type R review: $200,000 driving experience for less than half price?
If I had never driven the 2026 Porsche 911 GT3 Touring with a manual transmission, that statement might sound ridiculous. But I can’t stop thinking about the Honda Civic Type ...
Honda is looking to compete in the bigger three-row SUV segment by introducing a “Pilot XXL,” according to an Automotive News report, with a production date at least six years away. Though the current ...
The auto industry has embraced a bigger is better attitude, especially when it comes to SUVs. An assortment of supersized models have rolled out recently and a new report suggests Honda could follow ...
Three-row SUVs, in case you hadn’t taken a look around the parking lot during your last trip to Costco, are big business in the United States. Big not just in the sense of popularity—though they’re ...
Honda is reportedly considering a larger three-row flagship SUV that would slot above the current Pilot and take direct aim at the Ford Explorer and Toyota Grand Highlander, with a target launch of ...
Good morning and welcome to The Downshift, a daily sweep of today’s top headlines from the auto industry and car culture, curated by The Drive’s editorial team. Each story gets a short summary and a ...
Every manufacturer approaches its certified pre-owned (CPO) program differently, and Honda’s approach — called HondaTrue — focuses on offering excellent warranty extensions for relatively small ...
Yoichiro Fukao will replace Tetsushi Kakuda as leader of Honda's Formula 1 power unit program on October 1 as the manufacturer prepares its next development phase with Aston Martin. The handover comes ...
When a fire truck is racing to an emergency, every second counts. A new pilot program launched in Detroit is testing technology designed to help fire and EMS vehicles move through intersections faster ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Tuesday formally launched an initiative designed to speed up early clinical trials for new ...
Margaret is a Washington correspondent covering the Food and Drug Administration and other federal health agencies. Reach her on Signal at margaretmanto.61. WASHINGTON — The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results